Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Heron Therapeutics (HRTX) Return on Assets (2016 - 2025)

Heron Therapeutics' Return on Assets history spans 13 years, with the latest figure at 0.01% for Q4 2025.

  • For Q4 2025, Return on Assets rose 4.0% year-over-year to 0.01%; the TTM value through Dec 2025 reached 0.01%, up 4.0%, while the annual FY2025 figure was 0.04%, 2.0% up from the prior year.
  • Return on Assets reached 0.01% in Q4 2025 per HRTX's latest filing, down from 0.01% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.01% in Q3 2025 to a low of 0.84% in Q2 2022.
  • Average Return on Assets over 5 years is 0.44%, with a median of 0.58% recorded in 2021.
  • Peak YoY movement for Return on Assets: dropped -28bps in 2021, then surged 44bps in 2024.
  • A 5-year view of Return on Assets shows it stood at 0.66% in 2021, then decreased by -1bps to 0.67% in 2022, then grew by 27bps to 0.49% in 2023, then soared by 90bps to 0.05% in 2024, then skyrocketed by 80bps to 0.01% in 2025.
  • Per Business Quant, the three most recent readings for HRTX's Return on Assets are 0.01% (Q4 2025), 0.01% (Q3 2025), and 0.01% (Q2 2025).